Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon lambda-1a vs peginterferon alfa-2a plus ribavirin in treatment-naive genotype 1 chronic hepatitis C
2012-003508-11Phase 3Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2013
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon lambda-1a in hepatitis C virus infection, sponsored by Bristol Myers Squibb. Started Apr 2013; status: terminated.
02
Drugs
peginterferon lambda-1a
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2012-003508-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003508-11.